Picture of NRX Pharmaceuticals logo

NRXP — NRX Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: NRx Pharmaceuticals Reports Q2 Net Loss Of $7.0 Million Compared With A Net Loss Of $0.1 Million

Aug 15 (Reuters) - NRX Pharmaceuticals Inc  NRXP.O :
    * NRX PHARMACEUTICALS PROVIDES BUSINESS UPDATE AND REPORTS
SECOND
QUARTER 2022 RESULTS FOCUSING ON REACTIVATION & ADVANCEMENT OF
ITS PSYCHIATRY FRANCHISE
    * NRX PHARMACEUTICALS INC QTRLY NET LOSS WAS $7.0 MILLION
COMPARED
WITH A NET LOSS OF $0.1 MILLION
    * NRX PHARMACEUTICALS INC - COMPLETED MANUFACTURE OF PHASE
3/COMMERCIAL READY ZYESAMI

Source text for Eikon:  ID:nPn4s1P07a 
Further company coverage:  NRXP.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on NRX Pharmaceuticals

See all news